To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)

NCT00363545 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1274

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL: Lyophilized formulation of HRV vaccine
BIOLOGICAL: Liquid formulation of HRV vaccine

Sponsor

GlaxoSmithKline